Chest Journal Podcasts

Paul E. Marik, MD, FCCP, and Editorialist Heleen M. Oudemans-van Straaten, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss Dr. Marik and colleagues' retrospective study of the effectiveness in treating patients with severe sepsis and specific shock with the early use of intravenous vitamin C, together with corticosteroids and thiamine.

Ahmed H. El-Sherief, MD, and editorialist Galit Aviram, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss the study by Dr. El-Sherief and others on the inconsistencies in lymph node classification and the need for a lymph node map that simultaneously communicates a standard set of lymph node station definitions in three languages—using the language of anatomic landmarks for surgeons, bronchoscopic landmarks for pulmonologists, and visual CT landmarks for radiologists.

Gregory A. Schmidt, MD, FCCP, and Pierre Kory, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss their Point/Counterpoint debate on the value of inferior vena cava ultrasound to determine the use of acute fluid resuscitation for patients in shock.

Chanu Rhee, MD, MPH, and Robert C. Hazy, MD, FCCP, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to review and analyze the results of Dr. Rhee et al's research estimating incidences and mortality of septic shock over a ten-year period. Their results showed that the incidence has risen but mortality rates have fallen.

Brian Funaki, MD, and Mark L. Lessne, MD, joint CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss this month's Point/Counterpoint debate: Do the Benefits Outweigh the Risks for Most Patients Under Consideration for Inferior Vena Cava Filters?

Alain Tremblay, MD, and editorialist David E. Ost, MD, FCCP, joined CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the research by multi-center Canadian study by Tremblay et al that evaluated how well autofluorescence bronchochoscopy (AFB) detected high-grade lesions in patients at risk for lung cancer. Their study determined that too few CT occult cancers were detected to justify its addition into a lung cancer screening program.

Devanand Anantham, MD, and Ching-Fei Chang, MD, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to discuss the multi-country Asian adaption of guidelines to evaluate pulmonary nodules.

Anand Padmanabhan, MD, joins David A. Garcia, MD, FCCP, and guest podcast moderator, Bruce L. Davidson, MD, FCCP, to discuss the results of the research of Dr. Padmanabhan et al on a PF4-dependent platelet activation assay to identify patients likely to have heparin-induced thrombocytopenia/thrombosis.

Lisa A. Maier, MD, MSPH, and Elliott D. Crouser, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the study by Dr. Maier and her colleagues looking at data from death certificates to assess the association between occupations and sarcoidosis.

Curtis N. Sessler, MD, FCCP, and Stephen M. Pastores, MD, FCCP, join CHEST podcast editor D. Kyle Hogarth, MD, FCCP, to discuss this important topic, which is being addressed by the Critical Care Societies Collaborative "call to action" statement.

In this month's podcast, Pietro Caironi, MD, and Angel O. Coz Yataco, MD, FCCP take on the Point/Counterpoint topic with CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP. Dr. Caironi takes the "Yes" side, arguing that albumin has been shown to correct for hypoalbumenia in patients with sepsis. Dr. Coz Yataco takes the opposing view that mortality rates are not shown to improve and that the cost is high.

Steven Simpson, MD, and Clifford S. Deutschman, MD, MS, join CHEST Podcast D. Kyle Hogarth, MD, FCCP to discuss the merits of the new Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), recently published in JAMA. Dr. Simpson wrote an editorial for CHEST on this topic.

Dr. Wheeler was interviewed by CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP on the path of career and the highlights of his life's work.

Gurinder Singh, MD, and editorialist Abebaw Yohannes, PhD, FCCP, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to discuss the close association of psychological disorders, with 30-day readmission rates in patients with COPD.

Mark L. Metersky, MD, FCCP, and Scott Manker, MD, FCCP, discuss the merits of injectable corticotropin vs. corticosteroids with CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, given the exponentially higher cost of the former.

Clive Kearon, MD, PhD, and COL Lisa K. Moores, MC, USA, FCCP, join CHEST Evidence-Based Medicine Section Editor, Ian T. Nathanson, MD, FCCP, to review the important updates to the VTE Guidelines. This is the first of the topic updates to CHEST since the move to a "living guidelines" model, where topics will be updated on a rolling basis, not compiled into a single supplement containing all updates.

Courtney R. Bruce, JD, MA, and Trevor Bibler, PhD, joint CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss how their institution navigates and interprets differences in written advance directives and in-person requests from surrogate decision makers. They highlight one case study to demonstrate their process.

Borja G. Cosio, MD, and Peter Barnes, MD, Master FCCP, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss Dr. Cosio et al's study that proposes diagnostic criteria to identify patients with asthma-COPD overlap syndrome (ACOS).

Renda Soylenz Wiener, MD, MPH; Nichole T. Tanner, MD, MSCR; and editorialist David R. Baldwin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss a series of articles in this month's issue of CHEST focusing on pulmonary nodules and whether guidelines affect decisions on patient diagnosis and treatment.

Paul P. Walker, MD, and editorialist David M. Mannino, MD, FCCP, are interviewed by CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to review the research by Walker et al on heroin smokers and their risk of developing COPD at an early age.